摘要微创手术有助于减少手术创伤和疼痛，帮助患者康复，改善生活质量。包括胸腔镜和机器人在内的微创肺切除术目前主要用于早期周围型肺癌的外科治疗，中央型肺癌由于肿瘤位置、淋巴结转移和治疗模式等原因，手术难度较大、技术要求较高，尤其是袖状切除术和全肺切除术，大多需要开胸手术切除。随着微创手术技术的不断进步，近年来临床上开始尝试将其应用于中央型肺癌的外科治疗，其可行性和安全性已得到初步结果证明，代表了微创胸肺癌外科的发展方向。但仍需要更多研究结果证实其功能优越性和肿瘤学效果，让更多肺癌患者从外科技术的进步中获益。

abstractsMinimally invasive surgery helps enhance postoperative recovery and improve quality of life of the patients by minimizing surgical trauma and decreasing incisional pain. Minimally invasive pulmonary resection, including both video-assisted thoracoscopic surgery and robotic surgery, is mainly used for surgical management of peripheral early stage lung cancers. Because of tumor location, lymph node involvement, and treatment modalities, surgery for central lung cancers is often technically demanding. Open thoracotomy is still the dominant approach for these tumors, especially when complex procedures such as sleeve lobectomy or pneumonectomy are needed. With the advent of surgical techniques, minimally invasive techniques have started to be tried in treatment of central lung cancers. Initial results have proven their feasibility and safety in sleeve lobectomy and pneumonectomy, showing a great potential of minimally invasive surgery in the future. Further study is necessary to prove its functionally superiority and oncological equivalence to open surgery, so that more lung cancer patients could benefit for minimally invasive surgery.